đź”— Share this article Chancellor Rachel Reeves Intends Specific Action on Living Costs in Forthcoming Budget Treasury head Rachel Reeves has revealed she is preparing "focused measures to address household expense issues" in the upcoming financial statement. Speaking to media outlets, she emphasized that reducing inflation is a shared duty of both the government and the central bank. The United Kingdom's inflation rate is expected to be the most elevated among the G7 industrialized countries this year and the following year. Potential Utility Bill Interventions Sources suggest the government could take action to lower energy bills, such as by slashing the present 5% rate of VAT charged on energy supplies. A further possibility is to lower some of the regulatory levies presently included in household expenses. Fiscal Constraints and Expert Expectations The government will obtain the next draft from the official forecaster, the OBR, on the start of the week, which will reveal how much space there is for such measures. The expectation from the majority of analysts is that Reeves will have to announce tax increases or spending cuts in order to fulfill her declared fiscal targets. Previously on the same day, analysis suggested there was a ÂŁ22bn deficit for the chancellor to address, which is at the lower end of forecasts. "There's a joint job between the Bank of England and the administration to continue tackling some of the sources of inflation," the Chancellor told the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank. Tax Pledges and Global Issues While much of the attention has been on probable tax rises, the Treasury chief said the most recent data from the OBR had not altered her pledge to election pledges not to raise rates on earnings tax, sales tax or social security contributions. She blamed an "uncertain world" with growing international and trade issues for the Budget tax moves, probably to be directed on those "wealthiest." Global Economic Disputes Addressing concerns about the United Kingdom's economic relations with China she said: "Our security interests always are paramount." Recent announcement by China to tighten export controls on rare earths and other resources that are essential for advanced tech manufacturing led US President Donald Trump to propose an extra 100% tariff on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two economic giants. The US Treasury Secretary labeled the Chinese action "economic coercion" and "a international production power grab." Questioned on considering the American proposal to join its conflict with China, the Chancellor said she was "deeply worried" by Chinese actions and encouraged the Chinese government "to avoid restrictions and limit trade." She said the decision was "damaging for the international commerce and causes additional obstacles." "In my view there are fields where we need to confront Chinese policies, but there are also important chances to trade with China's economy, including financial services and other areas of the economy. We've got to maintain that equilibrium correct." The Treasury chief also confirmed she was working with other major economies "regarding our own critical minerals strategy, so that we are less reliant." Health Service Drug Costs and Investment Reeves also recognized that the price the National Health Service pays for medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in exchange for lower tariffs and investment. Some of the world's largest drug companies have said in recent statements that they are either halting or canceling operations in the United Kingdom, with some blaming the low prices they are receiving. Recently, the government science advisor said the price the health service spends on medicines would must rise to prevent firms and pharmaceutical investment departing from the UK. Reeves told the BBC: "It has been observed due to the cost structure, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other European countries." "We want to ensure that individuals getting treatment from the NHS are can obtain the best life-saving medicines in the world. And so we are reviewing all of that, and... seeking to attract more funding into Britain."